Immune responses to pertussis antigens in infants and toddlers after immunization with multicomponent acellular pertussis vaccine

Clinical and Vaccine Immunology

Volumn 21, Issue 12, 2014, Pages 1613-1619

  Fadugba, Olajumoke O ^a   Wang, Li ^a   Chen, Qingxia ^a   Halasa, Natasha B ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE;

BLOOD; BORDETELLA PERTUSSIS; CHILD; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; PRESCHOOL CHILD; VACCINATION; WHOOPING COUGH;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HUMANS; INFANT; MALE; VACCINATION; WHOOPING COUGH;

EID: 84914145486     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00438-14     Document Type: Article

References (50)

1. Higgs R, Higgins SC, Ross PJ, Mills KH. 2012. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol. 5:485-500. http://dx.doi.org/10.1038/mi.2012.54.
2. Ross PJ, Sutton CE, Higgins S, Allen AC, Walsh K, Misiak A, Lavelle EC, McLoughlin RM, Mills KH. 2013. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog. 9:e1003264. http://dx.doi.org/10.1371/journal.ppat.1003264.
3. Centers for Disease Control and Prevention. 2012. Pertussis: surveillance & reporting. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/pertussis/surv-reporting.html.
4. Guris D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, Wharton M, Livengood JR. 1999. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin. Infect. Dis. 28:1230-1237. http://dx.doi.org/10.1086/514776.
5. Pickering LK (ed). 2012. Red book, 29th ed, p 553-566. American Academy of Pediatrics, Elk Grove Village, IL.
6. Cherry JD. 2013. Pertussis: challenges today and for the future. PLoS Pathog. 9:e1003418. http://dx.doi.org/10.1371/journal.ppat.1003418.
7. Bamberger ES, Srugo I. 2008. What is new in pertussis? Eur. J. Pediatr. 167:133-139. http://dx.doi.org/10.1007/s00431-007-0548-2.
8. Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, Zell E, Martin S, Messonnier NE, Clark TA, Skoff TH. 2013. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics 131:e1047-e1052. http: //dx.doi.org/10.1542/peds.2012-1928.
9. Edwards KM. 2014. Unraveling the challenges of pertussis. Proc. Natl. Acad. Sci. U. S. A. 111:575-576. http://dx.doi.org/10.1073/pnas.1321360111.
10. Schure RM, Hendrikx LH, de Rond LG, Ozturk K, Sanders EA, Berbers GA, Buisman AM. 2013. Differential T-and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination. Clin. Vaccine Immunol. 20:1388-1395. http://dx.doi.org/10.1128/CVI.00270-13.
11. Ausiello CM, Lande R, Urbani F, Di Carlo B, Stefanelli P, Salmaso S, Mastrantonio P, Cassone A. 2000. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. J. Infect. Dis. 181:1989-1995. http://dx.doi.org/10.1086/315509.
12. Ausiello CM, Urbani F, La Sala A, Lande R, Piscitelli A, Cassone A. 1997. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis. Dev. Biol. Stand. 89:315-320.
13. Cassone A, Ausiello CM, Urbani F, Lande R, Giuliano M, La Sala A, Piscitelli A, Salmaso S. 1997. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group. Arch. Pediatr. Adolesc. Med. 151:283-289. http://dx.doi.org/10.1001/archpedi.1997.02170400069013.
14. Rieber N, Graf A, Belohradsky BH, Hartl D, Urschel S, Riffelmann M, Wirsing von Konig CH, Liese J. 2008. Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination. Vaccine 26:6929-6935. http://dx.doi.org/10.1016/j.vaccine.2008.09.064.
15. Mahon BP, Sheahan BJ, Griffin F, Murphy G, Mills KH. 1997. Atypical disease after Bordetella pertussis respiratory infection of mice with tar-geted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes. J. Exp. Med. 186:1843-1851. http://dx.doi.org/10.1084/jem.186.11.1843.
16. Mascart F, Hainaut M, Peltier A, Verscheure V, Levy J, Locht C. 2007. Modulation of the infant immune responses by the first pertussis vaccine administrations. Vaccine 25:391-398. http://dx.doi.org/10.1016/j.vaccine.2006.06.046.
17. Mascart F, Verscheure V, Malfroot A, Hainaut M, Pierard D, Temerman S, Peltier A, Debrie AS, Levy J, Del Giudice G, Locht C. 2003. Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses. J. Immunol. 170:1504-1509. http://dx.doi.org/10.4049/jimmunol.170.3.1504.
18. Ryan M, Gothefors L, Storsaeter J, Mills KH. 1997. Bordetella pertussisspecific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice. Dev. Biol. Stand. 89:297-305.
19. Ryan M, Murphy G, Gothefors L, Nilsson L, Storsaeter J, Mills KH. 1997. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J. Infect. Dis. 175: 1246-1250. http://dx.doi.org/10.1086/593682.
20. Ryan M, Murphy G, Ryan E, Nilsson L, Shackley F, Gothefors L, Oymar K, Miller E, Storsaeter J, Mills KH. 1998. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93:1-10. http://dx.doi.org/10.1046/j.1365-2567.1998.00401.x.
21. Zepp F, Knuf M, Habermehl P, Schmitt HJ, Meyer C, Clemens R, Slaoui M. 1997. Cell-mediated immunity after pertussis vaccination and after natural infection. Dev. Biol. Stand. 89:307-314.
22. Zepp F, Knuf M, Habermehl P, Schmitt JH, Rebsch C, Schmidtke P, Clemens R, Slaoui M. 1996. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect. Immun. 64:4078-4084.
23. Cherry JD, Heininger U, Christenson PD, Eckhardt T, Laussucq S, Hackell JG, Mezzatesta JR, Stehr K. 1995. Surrogate serologic tests for the prediction of pertussis vaccine efficacy. Ann. N. Y. Acad. Sci. 754:359-363. http://dx.doi.org/10.1111/j.1749-6632.1995.tb44470.x.
24. Deen JL, Mink CA, Cherry JD, Christenson PD, Pineda EF, Lewis K, Blumberg DA, Ross LA. 1995. Household contact study of Bordetella pertussis infections. Clin. Infect. Dis. 21:1211-1219. http://dx.doi.org/10.1093/clinids/21.5.1211.
25. Meyer CU, Zepp F, Decker M, Lee M, Chang SJ, Ward J, Yoder S, Bogaert H, Edwards KM. 2007. Cellular immunity in adolescents and adults following acellular pertussis vaccine administration. Clin. Vaccine Immunol. 14:288-292. http://dx.doi.org/10.1128/CVI.00364-06.
26. Nakayamada S, Takahashi H, Kanno Y, O'Shea JJ. 2012. Helper T cell diversity and plasticity. Curr. Opin. Immunol. 24:297-302. http://dx.doi.org/10.1016/j.coi.2012.01.014.
27. Hirahara K, Vahedi G, Ghoreschi K, Yang XP, Nakayamada S, Kanno Y, O'Shea JJ, Laurence A. 2011. Helper T-cell differentiation and plasticity: insights from epigenetics. Immunology 134:235-245. http://dx.doi.org/10.1111/j.1365-2567.2011.03483.x.
28. Rieber N, Graf A, Hartl D, Urschel S, Belohradsky BH, Liese J. 2011. Acellular pertussis booster in adolescents induces Th1 and memory CD8 T cell immune response. PLoS One 6:e17271. http://dx.doi.org/10.1371/journal.pone.0017271.
29. Ausiello CM, Lande R, Urbani F, la Sala A, Stefanelli P, Salmaso S, Mastrantonio P, Cassone A. 1999. Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines. Infect. Immun. 67:4064-4071.
30. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigenspecific proliferation and cytokine production. J. Immunol. 150:353-360.
31. Rock MT, Yoder SM, Talbot TR, Edwards KM, Crowe JE, Jr. 2004. Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels. J. Infect. Dis. 189:1401-1410. http://dx.doi.org/10.1086/382510.
32. Tarnok A, Hambsch J, Chen R, Varro R. 2003. Cytometric bead array to measure six cytokines in twenty-five microliters of serum. Clin. Chem. 49:1000-1002. http://dx.doi.org/10.1373/49.6.1000.
33. Tomoda T, Ogura H, Kurashige T. 1991. Immune responses to Bordetella pertussis infection and vaccination. J. Infect. Dis. 163:559-563. http://dx.doi.org/10.1093/infdis/163.3.559.
34. Robbins JB, Schneerson R, Keith JM, Miller MA, Kubler-Kielb J, Trollfors B. 2009. Pertussis vaccine: a critique. Pediatr. Infect. Dis. J. 28:237-241. http://dx.doi.org/10.1097/INF.0b013e31818a8958.
35. Watanabe M, Connelly B, Weiss AA. 2006. Characterization of serological responses to pertussis. Clin. Vaccine Immunol. 13:341-348. http://dx.doi.org/10.1128/CVI.13.3.341-348.2006.
36. Hallander HO, Ljungman M, Jahnmatz M, Storsaeter J, Nilsson L, Gustafsson L. 2009. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection. APMIS 117:660-671. http://dx.doi.org/10.1111/j.1600-0463.2009.02521.x.
37. Storsaeter J, Hallander HO, Gustafsson L, Olin P. 1998. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16:1907-1916. http://dx.doi.org/10.1016/S0264-410X(98)00227-8.
38. Centers for Disease Control and Prevention. 1997. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend. Rep. 46:1-25.
39. WHO. 2010. Pertussis vaccines: WHO position paper. Wkly. Epidemiol. Rec. 85:385-400.
40. Pawloski LC, Queenan AM, Cassiday PK, Lynch AS, Harrison MJ, Shang W, Williams MM, Bowden KE, Burgos-Rivera B, Qin X, Messonnier N, Tondella ML. 2014. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin. Vaccine Immunol. 21:119-125. http://dx.doi.org/10.1128/CVI.00717-13.
41. Mills KH, Barnard A, Watkins J, Redhead K. 1993. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:399-410.
42. Ausiello CM, Urbani F, la Sala A, Lande R, Cassone A. 1997. Vaccineand antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect. Immun. 65:2168-2174.
43. Ryan EJ, Nilsson L, Kjellman N, Gothefors L, Mills KH. 2000. Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens. Clin. Exp. Immunol. 121:193-200. http://dx.doi.org/10.1046/j.1365-2249.2000.01306.x.
44. Scheifele DW, Ochnio JJ, Halperin SA. 2009. Cellular immunity as a potential cause of local reactions to booster vaccination with diphtheria and tetanus toxoids and acellular pertussis antigens. Pediatr. Infect. Dis. J. 28:985-989. http://dx.doi.org/10.1097/INF.0b013e3181a9cc2a.
45. Rowe J, Macaubas C, Monger T, Holt BJ, Harvey J, Poolman JT, Loh R, Sly PD, Holt PG. 2001. Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic Th1 function. J. Infect. Dis. 184:80-88. http://dx.doi.org/10.1086/320996.
46. Barenkamp SJ, Leininger E. 1992. Cloning, expression, and DNA sequence analysis of genes encoding nontypeable Haemophilus influenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis. Infect. Immun. 60:1302-1313.
47. He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. 1998. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA 280:635-637. http://dx.doi.org/10.1001/jama.280.7.635.
48. Isacson J, Trollfors B, Taranger J, Lagergard T. 1995. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis. Pediatr. Infect. Dis. J. 14:517-521. http://dx.doi.org/10.1097/00006454-199506000-00009.
49. Mills KH, Ryan M, Ryan E, Mahon BP. 1998. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66:594-602.
50. Warfel JM, Zimmerman LI, Merkel TJ. 2014. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc. Natl. Acad. Sci. U. S. A. 111:787-792. http://dx.doi.org/10.1073/pnas.1314688110.